KPT-330 Prevents Aortic Valve Calcification via a Novel C/EBPβ Signaling Pathway.

Rationale: Calcific Aortic Valve Disease (CAVD) affects more than 5.2 million people in the US. The only effective treatment is surgery and this comes with complications and no guarantee of long-te...